⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVS News
Corvus Pharmaceuticals, Inc.
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
globenewswire.com
CRVS
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com
CRVS
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
globenewswire.com
CRVS
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
CRVS
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
globenewswire.com
CRVS
Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
globenewswire.com
CRVS